Recombinant HBxAg Production For Anti-cancer Therapeutic

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA105919-01
Agency Tracking Number:
CA105919
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
PROTEOMTECH, INC.
PROTEOMTECH, INC., 5980 HORTON ST, STE 405, EMERYVILLE, CA, 94608
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
XINLI Lin
(510) 597-9134
MEDYNSKI@PROTEOMTECH-INC.COM
Business Contact:
CHARLES GAO
(510) 597-9133
GAO@PROTEOMTECH-INC.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by investigator): Chronic infection with hepatitis B virus (HBV) is associated with a high incidence of liver diseases, including hepatocellular carcinoma (HCC). Hepatitis B virus x antigen (HBxAg), one of the four proteins encoded b

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government